Parul Kamboj

Statistics

Publications

Citations

233

H-Index

Active since

2018

Affiliations

Translational Health Science and Technology Institute(Current)

National Institute of Pharmaceutical Education and Research

Institute of Advanced Study in Science and Technology

Parul Kamboj is an author at Translational Health Science and Technology Institute specializing in pharmacology, metabolic regulation, and liver disease.

ORCID

Publications per year

2018–2023

Publications

Pathophysiology and management of alzheimer’s disease: an overview

Ajit Kumar Thakur, Parul Kamboj, Kritika Goswami et al. · Journal of Analytical & Pharmaceutical Research · 2018 · 136 citations · Full text

Medicine, Neurology, Pharmacology +17

Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids

Soumalya Sarkar, Deepika Kumari, Sonu Gupta et al. · Biomedicine & Pharmacotherapy · 2021 · 27 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD

Ayushi Purohit, Bharti Kandiyal, Shakti Kumar et al. · iScience · 2023 · 19 citations · Full text

Life Sciences, Microbiology, Inflammation +16

Evaluation of therapeutic effect of Premna herbacea in diabetic rat and isoverbascoside against insulin resistance in L6 muscle cells through bioenergetics and stimulation of JNK and AKT/mTOR signaling cascade

Bhaswati Kashyap, Sagar Barge, Simanta Bharadwaj et al. · Phytomedicine · 2021 · 16 citations

Life Sciences, Biochemistry, Pharmacology +13

Effect of herbal extracts and Saroglitazar on high-fat diet-induced obesity, insulin resistance, dyslipidemia, and hepatic lipidome in C57BL/6J mice

Deepika Kumari, Jyoti Gautam, Vipin Sharma et al. · Heliyon · 2023 · 13 citations · Full text

Medicine, Nutritional Sciences, Pharmacology +17

1–5 of 7